Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C VirusCoinfected Patients With Compensated Cirrhosis

Author： Mira Jos A.   Rivero-Jurez Antonio   Lpez-Corts Luis F.   Girn-Gonzlez Jos A.   Tllez Francisco   Santos-Gil Ignacio de los   Macas Juan   Merino Dolores   Mrquez Manuel   Ros-Villegas Mara J.   Gea Isabel   Merchante Nicols   Rivero Antonio   Torres-Cornejo Almudena   Pineda Juan A.  

Publisher： Oxford University Press

ISSN： 1058-4838

Source： Clinical Infectious Diseases, Vol.56, Iss.11, 2013-06, pp. : 1646-1653

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictability of Sustained Virological Response to Pegylated Interferon Alpha-2b Plus Ribavirin Therapy by Week-8 Viral Response in HIVPositive Patients with Chronic Hepatitis C Virus Infection

By  

Current HIV Research, Vol. 7, Iss. 4, 2009-07 ,pp. : 447-455

Bentham Science Publishers

Access to resources Recommend Favorite

Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin

By Perrella A.   Sbreglia C.   Atripaldi L.   Esposito C.   D'Antonio A.   Perrella O.  

Scandinavian Journal of Gastroenterology, Vol. 45, Iss. 2, 2010-02 ,pp. : 250-255

Informa Healthcare

Access to resources Recommend Favorite

Pegylated interferon and ribavirin combination therapy for chronic hepatitis C virus infection in patients with Child-Pugh Class A liver cirrhosis

By Syed Eliya   Rahbin Nogol   Weiland Ola   Carlsson Tony   Oksanen Antti   Birk Markus   Davidsdottir Loa   Hagen Karin   Hultcrantz Rolf   Aleman Soo  

Scandinavian Journal of Gastroenterology, Vol. 43, Iss. 11, 2008-01 ,pp. : 1378-1386

Informa Healthcare

Access to resources Recommend Favorite

Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C

By Tohra S.  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2449-2455

Springer Publishing Company

Access to resources Recommend Favorite

Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin

By Potthoff A.   Berg T.   Wedemeyer H.  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 12, 2009-12 ,pp. : 1487-1490

Informa Healthcare

Access to resources Recommend Favorite